NCT04282018 2026-02-20Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and TislelizumabBeOne MedicinesPhase 1/2 Completed97 enrolled 43 charts
NCT05651022 2026-01-13Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid TumorsIndaptus Therapeutics, IncPhase 1/2 Active not recruiting120 enrolled